L614-0107 Screening compound: N-(3-methylbutyl)-1-[4-(2,4,6-trimethylbenzenesulfonamido)benzoyl]pyrrolidine-2-carboxamide

L614-0107 Screening compound: N-(3-methylbutyl)-1-[4-(2,4,6-trimethylbenzenesulfonamido)benzoyl]pyrrolidine-2-carboxamide
L614-0107 Screening compound: N-(3-methylbutyl)-1-[4-(2,4,6-trimethylbenzenesulfonamido)benzoyl]pyrrolidine-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L614-0107
N-(3-methylbutyl)-1-[4-(2,4,6-trimethylbenzenesulfonamido)benzoyl]pyrrolidine-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L614-0107

Molecular Formula

C26H35N3O4S (C26 H35 N3 O4 S)

Compound Name

N-(3-methylbutyl)-1-[4-(2,4,6-trimethylbenzenesulfonamido)benzoyl]pyrrolidine-2-carboxamide

IUPAC name

N-(3-methylbutyl)-1-[4-(246-trimethylbenzenesulfonamido)benzoyl]pyrrolidine-2-carboxamide

SMILES

CC(C)CCNC(C(CCC1)N1C(c(cc1)ccc1NS(c1c(C)cc(C)cc1C)(=O)=O)=O)=O

InChI

InChI=1S/C26H35N3O4S/c1-17(2)12-13-27-25(30)23-7-6-14-29(23)26(31)21-8-10-22(11-9-21)28-34(32,33)24-19(4)15-18(3)16-20(24)5/h8-11,15-17,23,28H,6-7,12-14H2,1-5H3,(H,27,30)/t23-/m0/s1

InChI Key

FNMBKOFBIZLOOS-QHCPKHFHSA-N

MDL Number (MFCD)

MFCD27466038

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

485.65

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.692

Distribution Coefficient, logD

2.500

Water Solubility, LogSw

-4.26

Polar Surface Area

82.123

Acid Dissociation Constant (pKa)

5.21

Base Dissociation Constant (pKb)

2.91

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

46.20

L614-0107 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Anti-HIV1 Library (19540 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with L614-0107 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L614-0107?
Check Price and Availability of L614-0107, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L614-0107 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L614-0107
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L614-0107
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L614-0107 available by request